Complex, toxic or allergenic excipients• Enable injectable formulation
• Unstable formulation needing lyophilisation
• Drugs too unstable to be an injectable
• Need for ‘Cold chain’ to maintain stability
• Reconstitution of lyophilised powders
• Allergenic or toxic excipients
• Post reconstitution stability, single use only
• Incompatibility with injectable formulations
TPM
• A safer and more natural excipient
• Improve stability reducing need to lyophilise
• Allows previously unsuitable drugs to be injectable
• Reduce ‘cold chain’ by improving RT* stability
• Speed up reconstitution of lyophilised drugs
• Replace problem excipients
• Increase stability of reconstituted drugs –
potentially allowing multi-use products
- Forums
- ASX - By Stock
- POH
- Terumo and Propofol Injectable
Terumo and Propofol Injectable, page-14
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online